Michael Baldus
Impact in
- Hematology top 10%
- Chronic Myeloid Leukemia Treatments
- Acute Myeloid Leukemia Research
- Infectious Diseases top 10%
- Antifungal resistance and susceptibility
Papers in
-
- Acute Myeloid Leukemia Research 5
- Genetics 7
- Chronic Lymphocytic Leukemia Research 4
- Hemoglobinopathies and Related Disorders 2
- Co-authors
- Dieter Buchheidt (2 shared papers)Heyko Skladny (2 shared papers)Corinna Baust (2 shared papers)Thomas Suedhoff (1 shared paper)Rüediger Hehlmann (1 shared paper)Wolfgang Seifarth (1 shared paper)Joerg Ritter (1 shared paper)Rüdiger Hehlmann (1 shared paper)
- Journals
- British Journal of Haematology (2 papers)Anti-Cancer Drugs (1 paper)Leukemia (1 paper)Annals of Hematology (1 paper)Clinical Infectious Diseases (1 paper)
- Partner nations
- GermanyUnited StatesAustria
In The Last Decade
Michael Baldus
15 papers receiving 386 citations
Peers
Comparison fields: 5 of 57
- Hematology 137
- Infectious Diseases 194
- Genetics 78
- Small Animals 44
- Epidemiology 169
Countries citing papers authored by Michael Baldus
This map shows the geographic impact of Michael Baldus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Baldus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Baldus more than expected).
Fields of papers citing papers by Michael Baldus
This network shows the impact of papers produced by Michael Baldus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Baldus. The network helps show where Michael Baldus may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Baldus, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 133 | |
| 2 | 2002 | 78 | |
| 3 | 2020 | 64 | |
| 4 | 1998 | 49 | |
| 5 | 2000 | 37 | |
| 6 | 2003 | 13 | |
| 7 | Experience with zinc protoporphyrin as a marker of endogenous iron availability in chronic haemodialysis patients. | 1996 | 9 |
| 8 | 1999 | 9 | |
| 9 | Serum level changes of endogenous and postheparin diamine oxidase (histaminase) in clinical and experimental hepatitis. | 1976 | 6 |
| 10 | Transferrin receptor assay and zinc protoporphyrin as markers of iron-deficient erythropoiesis in end-stage renal disease patients. | 1998 | 5 |
| 11 | [Suramin--a new therapeutic principle in the treatment of metastatic adrenal gland cancer]. | 1990 | 1 |
| 12 | 2009 | 1 | |
| 13 | 2009 | 1 | |
| 14 | 2009 | 1 | |
| 15 | 2008 | 1 | |
| 16 | 2009 | 0 | |
| 17 | 2009 | 0 | |
| 18 | 2009 | 0 |
About Michael Baldus
Michael Baldus is a scholar working on Hematology, Genetics, Infectious Diseases, Pulmonary and Respiratory Medicine and Epidemiology, having authored 18 papers that have together received 408 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (5 papers), Chronic Lymphocytic Leukemia Research (4 papers), Fungal Infections and Studies (2 papers), Hemoglobinopathies and Related Disorders (2 papers), Antifungal resistance and susceptibility (2 papers), Immune Cell Function and Interaction (1 paper), Immunodeficiency and Autoimmune Disorders (1 paper) and Burkholderia infections and melioidosis (1 paper). The work is most often cited by research in Hematology (137 citations), Infectious Diseases (194 citations), Genetics (78 citations), Small Animals (44 citations) and Epidemiology (169 citations). Michael Baldus has collaborated with scholars based in Germany, United States and Austria. Frequent co-authors include Dieter Buchheidt, Heyko Skladny, Corinna Baust, Thomas Suedhoff, Rüediger Hehlmann, Wolfgang Seifarth, Joerg Ritter, Rüdiger Hehlmann, Susanne Bräuninger and Michael J. Uppenkamp. Their work appears in journals such as British Journal of Haematology, Anti-Cancer Drugs, Leukemia, Annals of Hematology and Clinical Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.